Updated:
AptarGroup
AptarGroup is a global packaging and delivery technology company serving pharma, beauty, and consumer markets.
AptarGroup
AptarGroup was founded in 1992 as a spin-off of Pittway Corporation's packaging operations, with its founding headquarters in Crystal Lake, Illinois. The company has since evolved into a diversified industrial firm focused on drug and consumer product dosing, dispensing, and protection technologies. The firm operates across three segments: Pharma, Beauty, and Closures. In Pharma, Aptar designs and manufactures drug delivery devices including nasal sprays, inhalers, and injectables. The Beauty segment produces dispensing pumps, aerosol valves, and airless packaging systems for fragrance, cosmetics, and skincare. Closures offers food, beverage, and home care packaging. Geographically, Aptar operates in North America, Europe, Asia, and Latin America, with manufacturing sites across over 20 countries. Aptar employs approximately 13,000 people worldwide and maintains R&D facilities in the US, Europe, and Asia. The company has been publicly traded on the NYSE under ticker ATR since 1993. In 2023, Aptar generated over $3.4 billion in revenue. Recent operational moves include the completion of its acquisition of global pharmaceutical services provider CSP Technologies in March 2021. Aptar's structural differentiator lies in its pure-play industrial manufacturing identity — it does not operate as an investment firm or family office. The company’s ownership structure includes significant institutional and public shareholders, with no indicated single-family-office control.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
St. Paul · London · San Francisco · Randor · Wayne · Crystal Lake
Sector focus
Frequently asked questions
Who runs investment decisions at AptarGroup?
AptarGroup is a publicly traded industrial company, not an investment firm. Investment decisions are made by its corporate management team led by CEO Stephan Tanda and the board of directors, subject to standard corporate governance. The company does not operate a dedicated investment arm or family office.
Does AptarGroup participate in fund commitments or only direct deals?
AptarGroup's capital deployment is focused on organic growth and strategic M&A related to its packaging and delivery technology businesses. The company does not participate in third-party fund commitments or direct investment deals as an allocator.
What investment stages does AptarGroup typically target?
AptarGroup engages in corporate M&A targeting established manufacturing and technology companies in packaging, drug delivery, and consumer product dosing. It does not target early-stage venture investments or fund-of-funds allocations.
Which sectors does AptarGroup explicitly avoid?
AptarGroup does not publish a list of prohibited sectors. Given its industrial focus, it does not invest in financial services, real estate, private equity funds, or other non-core asset classes.
How is AptarGroup related to AptarGroup's founding family?
AptarGroup was spun off from Pittway Corporation in 1992. The founding families of Pittway have no publicly disclosed ongoing governance role. The company is now publicly traded with institutional and retail shareholders.
Does AptarGroup maintain philanthropic structures, and how are they separated?
AptarGroup operates a corporate foundation: the AptarGroup Charitable Foundation. Contributions are made at the corporate level and are legally separate from the company's operating budget. There is no disclosed individual family foundation tied to the company.
What is AptarGroup's known posture on co-investments alongside external GPs?
AptarGroup does not engage in co-investments alongside external general partners. Its capital allocation strategy is confined to internal projects and acquisitions within its industrial and packaging core.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: